Nitta Gelatin India Reports Strong Profit Growth

Standalone Profit After Tax (PAT) Rises 30% to ₹25.19 Crore; Revenue Up 1.50%

Reader Takeaway: Profitable quarter with PAT growth; monitor customs duty litigation and subsidiary status.

What just happened

Nitta Gelatin India Ltd announced its standalone financial results for the quarter ended June 30, 2026. The company posted a profit after tax (PAT) of ₹25.19 crore, a significant increase of 30% compared to ₹19.38 crore in the same quarter last year. Standalone revenue saw a modest rise of 1.50%, reaching ₹140.87 crore from ₹138.79 crore in the prior-year period.

Consolidated profit for the period stood at ₹25.18 crore, which includes a loss from discontinued operations related to Bamni Proteins Limited.

Why this matters

The 30% jump in PAT signals improved profitability for Nitta Gelatin India. Shareholders will be keen to see this trend continue. The revenue growth, while smaller, indicates steady operational performance. The company is also managing its legal and operational challenges, which are crucial for sustained investor confidence.

The backstory

Nitta Gelatin India's financials reflect a consistent effort to improve earnings. The company has been dealing with a legacy customs duty matter from FY 2018-19, with a contingent liability of ₹18.20 crore. The Supreme Court granted an interim stay on the High Court's judgment in September 2025 regarding this matter.

Furthermore, its subsidiary, Bamni Proteins Limited, is classified as a discontinued operation and is not considered a going concern due to regulatory issues. This has been a point of focus for the company in recent periods.

What changes now

The company is initiating a postal ballot to appoint Mr. Arun K. Vijayan IAS as a Nominee Director from KSIDC, replacing Mr. Vishnuraj P IAS. This corporate action is a routine governance update.

Investors will now focus on the company's ability to maintain this profit trajectory and manage its existing legal contingencies, particularly the customs duty matter. The status of Bamni Proteins as a discontinued operation will also remain under observation.

Risks to watch

The primary risk remains the contingent liability of ₹18.20 crore related to the customs duty matter. Although an interim stay is in place, the final outcome could impact the company's financials. The regulatory issues surrounding Bamni Proteins also represent an ongoing concern.

Peer comparison

While specific peer data for Nitta Gelatin India's niche products like gelatin and collagen peptide is not readily available for immediate comparison in this filing, the company operates in the specialty chemicals and animal by-products sector. Generally, companies in this sector are assessed on their ability to manage raw material costs, regulatory compliance, and product innovation.

Context metrics (time-bound)

• Revenue (Standalone): ₹140.87 crore (Quarter ended June 30, 2026) vs ₹138.79 crore (Quarter ended June 30, 2025).
• PAT (Standalone): ₹25.19 crore (Quarter ended June 30, 2026) vs ₹19.38 crore (Quarter ended June 30, 2025).
• Contingent Liability (Customs Duty Matter): ₹18.20 crore (as of current filing).
• Provision Made: ₹1.49 crore.
• Supreme Court Stay: September 2025.

What to track next

Investors should closely monitor future quarterly results for sustained profit growth. Keep an eye on any developments regarding the customs duty litigation and the ultimate resolution of Bamni Proteins Limited's operational status. Any further governance changes or strategic decisions from the new Nominee Director will also be noteworthy.